Venus Medtech (Hangzhou) (HKSE:02500) FCF Yield % : -38.52 (As of May. 23, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Venus Medtech (Hangzhou) FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Venus Medtech (Hangzhou)'s Trailing 12-Month Free Cash Flow is HK$-954.8 Mil, and Market Cap is HK$2,478.5 Mil. Therefore, Venus Medtech (Hangzhou)'s FCF Yield % for today is -38.52%.

The historical rank and industry rank for Venus Medtech (Hangzhou)'s FCF Yield % or its related term are showing as below:

HKSE:02500' s FCF Yield % Range Over the Past 10 Years
Min: -56.49 Med: -8.07 Max: -1.15
Current: -38.52

During the past 7 years, the highest FCF Yield % of Venus Medtech (Hangzhou) was -1.15%. The lowest was -56.49%. And the median was -8.07%.

HKSE:02500's FCF Yield % is ranked worse than
84.25% of 870 companies
in the Medical Devices & Instruments industry
Industry Median: -2.77 vs HKSE:02500: -38.52

Venus Medtech (Hangzhou)'s FCF Margin % for the quarter that ended in Dec. 2023 was -206.38%.

Venus Medtech (Hangzhou) FCF Yield % Historical Data

The historical data trend for Venus Medtech (Hangzhou)'s FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Medtech (Hangzhou) FCF Yield % Chart

Venus Medtech (Hangzhou) Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-2.41

-1.28

-5.65

-16.13

-38.52

Venus Medtech (Hangzhou) Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial							-6.93	-13.83	-16.08	-31.16	-42.94

Competitive Comparison of Venus Medtech (Hangzhou)'s FCF Yield %

For the Medical Devices subindustry, Venus Medtech (Hangzhou)'s FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Venus Medtech (Hangzhou)'s FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Medtech (Hangzhou)'s FCF Yield % distribution charts can be found below:

* The bar in red indicates where Venus Medtech (Hangzhou)'s FCF Yield % falls into.

Venus Medtech (Hangzhou) FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Venus Medtech (Hangzhou)'s FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-954.789	/	2478.48182
	=	-38.52%

Venus Medtech (Hangzhou)'s annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-532.191	*	2	/	2478.48182
	=	-42.94%

Venus Medtech (Hangzhou) FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Venus Medtech (Hangzhou) FCF Yield % Related Terms

Thank you for viewing the detailed overview of Venus Medtech (Hangzhou)'s FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Medtech (Hangzhou) (HKSE:02500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Medtech (Hangzhou) Inc (HKSE:02500) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

VMTHF:USA

Address

No. 88, Jiangling Road, Room 311, 3rd Floor, Block 2, Binjiang District, Hangzhou, CHN, 310051

Website

https://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically all of the revenue is derived from Mainland China.

Venus Medtech (Hangzhou) (HKSE:02500) Headlines

No Headlines